General Information
Version
FSHBP2963
Revision date
2025-03-23
Product name
Rapamycin
Product Synonyms
(-)-Rapamycin; Sirolimus
CAS No.
53123-88-9
supplier name
Fisher Scientific Company
Icons in SDS
Company Information
company name
Fisher Scientific Company
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H361, H372
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture Carcinogenicity Category 2 Reproductive Toxicity Category 2 Specific target organ toxicity - (repeated exposure) Category 1 Label Elements
Signal word
Danger Hazard Statements H351 - Suspected of causing cancer H372 - Causes damage to organs through prolonged or repeated exposure H361 - Suspected of damaging fertility or the unborn child
Prevention
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P260 - Do not breathe dust/fume/gas/mist/vapors/spray P264 - Wash face, hands and any exposed skin thoroughly after handling P270 - Do not eat, drink or smoke when using this product P280 - Wear protective gloves/protective clothing/eye protection/face protection
Response
P308 + P313 - IF exposed or concerned: Get medical advice/attention
Storage
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed
Disposal
P501 - Dispose of contents/ container to an approved waste disposal plant
2.3 Other hazards
. . May form explosible dust-air mixture if dispersed. This product does not contain any known or suspected endocrine disruptors.
2.1 Classification of the substance or mixture
Carcinogenicity Category 2 Reproductive Toxicity Category 2 Specific target organ toxicity - (repeated exposure)
